Early Failure of Coronary Artery Bypass Grafts: An Albumin Cross-Linked Glutaraldehyde (BioGlue) Related Complication

Habib Khan, Sanjay Chaubey, Jatin Desai

Research output: Contribution to journalEditorialpeer-review

7 Citations (Scopus)

Abstract

P>Bioglue which constitutes albumin cross linked with glutaraldehyde (ACLG) produced by Cryolife, Inc, Kennesaw, GA was introduced as a better alternative to GRF glue with less tissue necrosis. We report a case of a 69-year-old male who developed stenosis of his saphenous vein and internal thoracic artery bypass grafts, requiring re-do coronary artery bypass grafting. Both fibrotic narrowing were in close proximity to the site of Bioglue application and appears to be a reaction to the glue. The advent of ACLG has facilitated surgery; however, this case highlights a potential side effect, emphasizing the judicious use of this hemostatic agent in patients. (J Card Surg 2011;26:264-266).
Original languageEnglish
Pages (from-to)264 - 266
Number of pages3
JournalJournal of Cardiac Surgery
Volume26
Issue number3
DOIs
Publication statusPublished - May 2011

Fingerprint

Dive into the research topics of 'Early Failure of Coronary Artery Bypass Grafts: An Albumin Cross-Linked Glutaraldehyde (BioGlue) Related Complication'. Together they form a unique fingerprint.

Cite this